ZNF217 confers resistance to the pro-apoptotic signals of paclitaxel and aberrant expression of Aurora-A in breast cancer cells
Aurélie Thollet(Institut du Thorax), Pascale A. Cohen(Lyon 1 Université), Evelyne Grisard(Lyon 1 Université), Julie A. Vendrell(Inserm), Colin C. Collins(University of British Columbia), Sandra E. Ghayad(Inserm), Léa Payen(Université Claude Bernard Lyon 1), Sabrina Ben Larbi(Lyon 1 Université), Marie Villedieu(Cancers et Préventions)
Cited by 51
Related Papers
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)
|The Lancet Oncology|2014|410
Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate Cancer
|JAMA Oncology|2016|384
Cracking the Estrogen Receptor's Posttranslational Code in Breast Tumors
|Endocrine Reviews|2011|302
Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response
|JAMA Oncology|2015|302